HDFC Pharma and Healthcare Fund - Regular Plan - Growth

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Category : Sectoral/Thematic

Fund House : HDFC Mutual Fund

NAV

This number shows latest NAV (Net Asset Value) and change in the NAV from previous day. NAV is nothing but the unit price for the fund. You will be allocated number of units based on this price. NAV is declared once each day generally at the end of the day. Once you invest in mutual funds, your money is further invested in stocks and bonds by mutual fund managers. Mutual Fund NAV is the per unit latest value of all such stocks/bonds held in the portfolio

: ₹ 17.401 0.04%
(as on 13th November, 2025)

Crisil Rating

Not Rated

Rank not available for the fund

Fund Size

: ₹ 1966.73 Cr

(0.37% of Investment in Category)

Expense Ratio

: 2.08%

(2.12% Category average)

Risk-O-Meter

Very High Risk

Sectoral/Thematic :Sectoral/Thematic : The fund has 98.31% investment in domestic equities of which 29.13% is in Large Cap stocks, 18.58% is in Mid Cap stocks, 13.67% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

1M
3M
6M
1Y
2Y
5Y
ALL

This Scheme

VS

Benchmark
BSE Healthcare TRI

0%

0%

0%

0%

0%

0%

0%
NA
1.56%

4.31%

8.08%

7.43%

18.97%

20.92%

12.58%

NA
Gold

Compare with

Date : -
NAV : -

1M
3M
6M
9M
1Y
2Y
3Y
5Y
ALL

Date : -
Investment : -
Value on selected date : -

Returns Calculator
SIP Calculator
VIP (Value Avg)

Amount

₹

Investment Date
Sell Date

Investment Value

-
Sell Value

-
Profit/Loss

-
Annualised Returns

-

Date : -
Investment : -
Value on selected date : -

Returns (NAV as on 12th November, 2025)

Period Invested for	₹10000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	04-Nov-25	9957.10	-0.43%	-	0.21%	178/241
1 Month	10-Oct-25	10086.40	0.86%	-	1.45%	159/238
3 Month	12-Aug-25	10138.70	1.39%	-	5.02%	216/236
6 Month	12-May-25	11009.60	10.10%	-	7.76%	49/225
YTD	01-Jan-25	10179.70	1.80%	-	4.39%	125/213
1 Year	12-Nov-24	10817.20	8.17%	8.17%	5.52%	61/199
2 Year	10-Nov-23	16755.60	67.56%	29.31%	19.16%	5/153
Since Inception	04-Oct-23	17455.10	74.55%	30.22%	12.65%	4/218

Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 12th November, 2025)

Period Invested for	₹1000 SIP Started on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	12-Nov-24	12000	12766.58	6.39 %	12 %
2 Year	10-Nov-23	24000	29072.58	21.14 %	19.57 %

SIP Calculator Detailed Returns Analysis

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Oct,2025)

Equity Holding : 98.31% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.31%

No of Stocks : 31 (Category Avg - 44.17) | Large Cap Investments : 29.13%| Mid Cap Investments : 18.58% | Small Cap Investments : 13.67% | Other : 36.93%

Top 10 Stocks in Portfolio

How to read this table?

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	2104.3	10.70%	0.23%	13.48% (Nov 2024)	10.39% (Aug 2025)	12.45 L	0.00
Divis Laboratories Ltd.	Pharmaceuticals	1745.5	8.87%	1.11%	10.24% (May 2025)	7.18% (Dec 2024)	2.59 L	556.00
Lupin Ltd.	Pharmaceuticals	1311.2	6.67%	-0.17%	6.84% (Sep 2025)	5.35% (Jan 2025)	6.68 L	-0.11 L
Glenmark Pharmaceuticals Ltd.	Pharmaceuticals	1189.3	6.05%	-0.88%	7.42% (Jul 2025)	2.99% (Feb 2025)	6.29 L	-0.44 L
Alkem Laboratories Ltd.	Pharmaceuticals	1147	5.83%	-0.11%	5.94% (Sep 2025)	0% (Nov 2024)	2.08 L	773.00
Max Healthcare Institute Ltd.	Hospital	1078.9	5.49%	0.83%	5.49% (Oct 2025)	2.03% (Nov 2024)	9.40 L	1.48 L
Ipca Laboratories Ltd.	Pharmaceuticals	810.1	4.12%	-0.38%	4.62% (Aug 2025)	3.26% (Jan 2025)	6.37 L	0.00
Laurus Labs Ltd.	Pharmaceuticals	747	3.80%	0.22%	3.8% (Oct 2025)	0% (Nov 2024)	7.83 L	-0.23 L
Aster DM Healthcare Ltd.	Hospital	728.9	3.71%	0.16%	3.92% (May 2025)	3.28% (Feb 2025)	10.75 L	0.00
Torrent Pharmaceuticals Ltd.	Pharmaceuticals	714.2	3.63%	-0.18%	3.88% (Jul 2025)	2.57% (Nov 2024)	2.01 L	0.00

- indicates change in weight in the portfolio. # indicates a new entry.

Detailed Portfolio Analysis

Name	Type of Instrument	Weight (%)
TREPS	TREPS	1.91%
Net Receivables	Net Receivables	-0.22%

Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth	NA	421.51	4.92	17.03	53.25	43.86	37.50
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth	NA	273.51	0.82	4.34	18.27	30.10	16.26
Quant BFSI Fund - Regular Plan - Growth	NA	680.73	4.10	7.82	19.29	25.75	0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth	NA	1733.63	0.81	10.48	23.11	25.46	0.00
Franklin Asian Equity Fund - Growth	NA	297.12	3.93	9.96	21.13	24.85	14.21
Nippon India Japan Equity Fund - Growth	NA	292.35	2.82	3.35	14.58	22.26	17.18
SBI Banking & Financial Services Fund - Regular Plan - Growth	NA	9273.44	3.02	6.26	11.05	21.03	19.27
DSP Banking & Financial Services Fund - Regular Plan - Growth	NA	1518.73	2.68	7.30	8.35	20.86	0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth	NA	333.18	3.77	7.72	8.27	20.77	13.19
UTI Transportation and Logistics Fund - Growth	NA	4008.33	-0.04	9.90	17.95	19.46	23.83

Detailed Comparison

More Funds from HDFC Mutual Fund

Out of 123 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 9 is/are ranked 4 * , 16 is/are ranked 3 * , 5 is/are ranked 2 * , 1 is/are ranked 1 * , and 88 schemes are not ranked. See more about AMC

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
HDFC Balanced Advantage Fund - Growth	4	106493.55	1.84	4.41	5.20	7.33	18.20
HDFC Flexi Cap Fund - Growth	5	91041.00	0.72	5.42	6.27	10.86	21.40
HDFC Mid Cap Fund - Growth	4	89383.23	3.28	6.85	12.25	10.33	26.12
HDFC Liquid Fund - Growth	3	61646.54	0.48	1.43	2.98	6.63	6.95
HDFC Large Cap Fund - Growth	3	39779.26	2.06	4.85	3.72	6.10	15.54
HDFC Large Cap Fund - Growth	3	39779.26	2.35	5.87	5.36	8.51	13.77
HDFC Small Cap Fund - Growth	4	38412.10	0.99	2.77	13.67	4.14	22.39
HDFC Money Market Fund - Growth	3	36903.78	0.51	1.47	3.42	7.52	7.49
HDFC Corporate Bond Fund - Growth	2	36133.95	0.57	1.72	3.24	7.88	7.88
HDFC Large and Mid Cap Fund - Regular - Growth	4	28486.64	1.78	5.69	8.24	7.52	20.24